Argenx
ARGX
#630
Rank
C$43.74 B
Marketcap
$721.61
Share price
0.56%
Change (1 day)
2.57%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.72 B

According to Argenx 's latest financial reports the company's total liabilities are C$0.72 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.43 B8.75%
2021-12-31C$0.39 B-57.61%
2020-12-31C$0.94 B50.83%
2019-12-31C$0.62 B773.58%
2018-12-31C$71.61 M52.33%
2017-12-31C$47.01 M-25.41%
2016-12-31C$63.02 M337.9%
2015-12-31C$14.39 M-0.52%
2014-12-31C$14.46 M115.53%
2013-12-31C$6.71 M-18.82%
2012-12-31C$8.26 M54.86%
2011-12-31C$5.34 M98.19%
2010-12-31C$2.69 M